Julia Weinmann-Menke

Prof. Julia Weinmann-Menke


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2026 in Die Innere Medizin
Verified
Journal Article
Closed access
JWJulia Weinmann-Menke
Julia Weinmann-Menke
JGJan Galle
Jan Galle

10 April 2026 in BMC Primary Care
Verified
Journal Article
Open access
PDF file
AKAndreas Kommer
Andreas Kommer
JWJulia Weinmann-Menke
Julia Weinmann-Menke
Karel KostevKarel Kostev
Karel Kostev
CLChristian Labenz
Christian Labenz
Background: The Check-up 35 has been a key element of primary prevention in German general practice since 1989. However, evidence on its effectiveness in detecting target diseases remains limited. Therefore, we analyzed the detection rates of the target diseases of the Check-up 35 in a large cohort of persons treated in German primary care. Methods: In a retrospective cohort study using data from 1,216 German primary care practices (IQVIA™ Disease Analyzer, 2019–2023), we compared Check-up 35 participants with non-participants via 1:5 propensity score matching. We analyzed diagnoses of arterial hypertension, diabetes mellitus, dyslipidemia, and chronic kidney disease (CKD) within three months post-check-up versus a random visit in controls. Medication prescriptions following diagnosis served as a secondary outcome. Results: We compared 51,829 participants with 259,145 matched non-participants. Participation was associated with higher diagnosis rates: hypertension (HR 1.56), diabetes (HR 1.69), dyslipidemia (HR 3.24), and CKD (HR 2.07). The effect was especially pronounced for dyslipidemia in individuals under 40 (HR 5.10). Prescription rates after diagnosis were similar or lower in the Check-up group. Conclusion: Check-up 35 is effective in early detection of key chronic diseases. Broader participation should be encouraged to improve prevention.